Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 May 1.

Published in final edited form as: J Allergy Clin Immunol Pract. 2018 Dec 21;7(5):1580–1588. doi: 10.1016/j.jaip.2018.12.014

Figure 3. — Changes in urinary LTE₄ (3A) and PGDM (3B) in urine during aspirin challenges after ESS in patients with and without clinical reactions to aspirin challenges.

Figure 3. — Changes in urinary LTE₄ (3A) and PGDM (3B) in urine during aspirin challenges after ESS in patients with and without clinical reactions to aspirin challenges.